Dimensional Fund Advisors LP Acquires 1,089,923 Shares of Envista Holdings Co. (NYSE:NVST)

Dimensional Fund Advisors LP raised its holdings in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 19.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,762,091 shares of the company's stock after purchasing an additional 1,089,923 shares during the quarter. Dimensional Fund Advisors LP owned approximately 3.93% of Envista worth $130,440,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC lifted its holdings in shares of Envista by 528.4% in the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company's stock worth $38,000 after purchasing an additional 1,638 shares in the last quarter. GAMMA Investing LLC increased its holdings in Envista by 30.5% during the 4th quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock worth $44,000 after acquiring an additional 538 shares during the period. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Envista during the fourth quarter valued at $53,000. Mitsubishi UFJ Trust & Banking Corp bought a new position in shares of Envista in the fourth quarter worth approximately $86,000. Finally, KBC Group NV increased its holdings in shares of Envista by 63.9% in the 4th quarter. KBC Group NV now owns 7,903 shares of the company's stock worth $152,000 after buying an additional 3,082 shares during the last quarter.

Envista Stock Up 1.9 %

Shares of NVST stock traded up $0.31 on Thursday, reaching $16.39. 1,213,007 shares of the company's stock traded hands, compared to its average volume of 2,513,593. The business's 50 day moving average price is $16.90 and its two-hundred day moving average price is $19.06. The company has a market capitalization of $2.78 billion, a P/E ratio of -2.53, a price-to-earnings-growth ratio of 1.27 and a beta of 1.12. Envista Holdings Co. has a 12-month low of $14.22 and a 12-month high of $23.00. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04.

Envista (NYSE:NVST - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, equities analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Jefferies Financial Group lifted their price target on Envista from $20.00 to $22.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Needham & Company LLC reiterated a "hold" rating on shares of Envista in a report on Thursday, March 6th. Bank of America cut their price target on Envista from $26.00 to $23.00 and set a "buy" rating for the company in a research note on Tuesday. Wells Fargo & Company set a $19.00 price objective on shares of Envista in a research note on Saturday, March 8th. Finally, Morgan Stanley set a $16.00 target price on shares of Envista in a report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $20.18.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.